Episode 227: ASRS ReST Report on Brolucizumab with Drs. Ajay Kuriyan, Shriji Patel, and Sarah Parker Read

227.png

Drs. Ajay Kuriyan, Shriji Patel, and Sarah Parker Read join the podcast to discuss the American Society of Retinal Specialists recently released Research and Safety in Therapeutics Committee report on brolucizimab associated inflammation and vision loss.

Relevant Financial Disclosures:
Dr. Sridhar: Consultant for Alimera, Regeneron
Dr. Kuriyan: Consultant and Research Funding Regeneron, Consultant for Novartis
Dr. Patel: Research with Regeneron, Novartis
Dr. Read: Consultant for Genentech

Register for the first VBS Online Meeting Episode on April 20th at 8:30pm ET!: https://us04web.zoom.us/webinar/register/WN_oc_crzw7RY2SCGYP4xW1vw

You can now claim CME credits via the AAO website. Visit https://www.aao.org/browse-multimedia?filter=Audio&sub=ONE.ContentTypes.Audio.